Hossein Borghaei, DO, MS: Dr Wirth, I’m going to ask you to outline, in a simplified fashion, the differences between germline mutations in a way that you would explain it to your patient in the ...
This transcript has been edited for clarity. For more episodes, download the Medscape app or subscribe to the podcast on Apple Podcasts, Spotify, or your preferred podcast provider. Sandhya Srinivas, ...
P4 Diagnostix has teamed with Pierian, a company that provides an analysis platform, to launch somatic testing for patients with prostate cancer. The partnership will further develop P4 Diagnostix’s ...
Reviewed by Vrunda Bhavsar Desai, MD, FACOG, Adjunct Assistant Professor of Obstetrics, Gynecology, and Reproductive Sciences, Yale School of Medicine, New Haven, CT Epithelial ovarian cancer accounts ...
Implementation of and Systems-Level Barriers to Guideline-Driven Germline Genetic Evaluation in the Care of Patients With Myelodysplastic Syndrome and Acute Myeloid Leukemia Somatic and germline ...
If a person develops pancreatic cancer, it may have genetic mutations that affect how it responds to treatment. Genetic testing can provide valuable information to help doctors and individuals make ...
ALISO VIEJO, Calif.--(BUSINESS WIRE)--Ambry Genetics (Ambry), a leader in clinical diagnostic testing, and Tempus, a leader in artificial intelligence and precision medicine, announced today that they ...
Comparison of Patient-Reported Peripheral Neuropathy Among Patients Treated With Elranatamab Versus Real-World Clinical Practice in Triple-Class Refractory Multiple Myeloma To our knowledge, no ...
Hosted on MSN
BRCA1 gene mutations may not be key to prostate cancer initiation, as previously thought
Mutations in the BRCA1 gene that are either inherited (germline) or acquired (somatic) might not be key to the initiation of prostate cancer, as previously thought, suggests the first study of its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results